Association of Community Cancer Centers Honors Researcher and Community Oncologist With National Award


Get Permission

John Powderly II, MD

In recognition of his dedication to cancer research and education, and for promoting the goals of cancer prevention, early detection, and quality cancer treatment, John Powderly II, MD, Certified Physician Investigator, President and Founder of Carolina BioOncology Institute, Huntersville, North Carolina, was recently honored with the Association of Community Cancer Centers (ACCC’s) 2014 David King Community Clinical Scientist Award.

Dr. Powderly is an Adjunct Clinical Assistant Professor of Medicine at Duke University and the University of North Carolina, Chapel Hill.

Champion of Community Oncology

“As a research clinician, Dr. Powderly exemplifies the spirit of Dr. King for whom this national award was named,” said ACCC President ­Virginia T. Vaitones, MSW, OSW-C. “Like Dr. King, Dr. Powderly has spent his career championing the value of the community clinical oncology program and raising awareness of the role of clinical research in the community cancer setting.”

ACCC’s prestigious award is named after David K. King, MD, FACP, who died after a brief battle with cancer. Dr. King had a long history with ACCC, serving in many capacities, including President of the Association. Dr. King dedicated his professional career to caring for individuals with cancer and advocating for access to quality care, the Community Clinical Oncology Program, and the value of clinical research in the community environment. “I am honored to have received this award,” said Dr. Powderly. “To be recognized for our hard work in fighting cancer and providing access to immunotherapy trials to patients in the Charlotte area is a wonderful validation of the clinic’s mission.”

David King Community Clinical Scientist Award winners become lifetime members of the ACCC National Academy of Community Oncology Scientists, which serves as a valuable resource to ACCC, the National Cancer Institute (NCI), pharmaceutical companies, and other organizations involved in community cancer research.

The award was presented during the ACCC 40th Annual National Meeting, held recently in Arlington, Virginia. ■



Advertisement

Advertisement



Advertisement